Lung cancer metastasis-related protein 1 promotes the transferring from advanced metastatic prostate cancer to castration-resistant prostate cancer by activating the glucocorticoid receptor α signal pathway

Androgen deprivation therapy is currently the main therapeutic strategy for the treatment of advanced metastatic prostate cancer (ADPC). However, the tumor type in ADPC patients transforms into castration-resistant prostate cancer (CRPC) after 18–24 months of treatments, the underlying mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Wang, Xuliang, Fu, Xian, Sun, Ji, Zhao, Liwei, He, Huadong, Fan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974197/
https://www.ncbi.nlm.nih.gov/pubmed/35184651
http://dx.doi.org/10.1080/21655979.2021.2020397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974197/
https://www.ncbi.nlm.nih.gov/pubmed/35184651
http://dx.doi.org/10.1080/21655979.2021.2020397

Ejemplares similares